SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-98-000032
Filing Date
1998-05-12
Accepted
1998-05-12 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D SC 13D/A 79315
  Complete submission text file 0001012168-98-000032.txt   81973
Mailing Address
Business Address 2545 CENTRAL AVE SUITE FDI BOULDER CO 80301 3034409988
SOMATOGEN INC (Subject) CIK: 0000818594 (see all company filings)

IRS No.: 840991858 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-45203 | Film No.: 98616624
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231